X-40581031-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005765.3(ATP6AP2):c.-35G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00196 in 1,162,744 control chromosomes in the GnomAD database, including 27 homozygotes. There are 622 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0099 ( 18 hom., 325 hem., cov: 24)
Exomes 𝑓: 0.0011 ( 9 hom. 297 hem. )
Consequence
ATP6AP2
NM_005765.3 5_prime_UTR
NM_005765.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00600
Genes affected
ATP6AP2 (HGNC:18305): (ATPase H+ transporting accessory protein 2) This gene encodes a protein that is associated with adenosine triphosphatases (ATPases). Proton-translocating ATPases have fundamental roles in energy conservation, secondary active transport, acidification of intracellular compartments, and cellular pH homeostasis. There are three classes of ATPases- F, P, and V. The vacuolar (V-type) ATPases have a transmembrane proton-conducting sector and an extramembrane catalytic sector. The encoded protein has been found associated with the transmembrane sector of the V-type ATPases. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant X-40581031-G-C is Benign according to our data. Variant chrX-40581031-G-C is described in ClinVar as [Benign]. Clinvar id is 136464.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00994 (1126/113284) while in subpopulation AFR AF= 0.0342 (1072/31308). AF 95% confidence interval is 0.0325. There are 18 homozygotes in gnomad4. There are 325 alleles in male gnomad4 subpopulation. Median coverage is 24. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 18 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATP6AP2 | NM_005765.3 | c.-35G>C | 5_prime_UTR_variant | 1/9 | ENST00000636580.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATP6AP2 | ENST00000636580.2 | c.-35G>C | 5_prime_UTR_variant | 1/9 | 1 | NM_005765.3 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00994 AC: 1125AN: 113235Hom.: 18 Cov.: 24 AF XY: 0.00915 AC XY: 324AN XY: 35401
GnomAD3 genomes
AF:
AC:
1125
AN:
113235
Hom.:
Cov.:
24
AF XY:
AC XY:
324
AN XY:
35401
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00237 AC: 245AN: 103268Hom.: 1 AF XY: 0.00149 AC XY: 55AN XY: 36924
GnomAD3 exomes
AF:
AC:
245
AN:
103268
Hom.:
AF XY:
AC XY:
55
AN XY:
36924
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1157AN: 1049460Hom.: 9 Cov.: 30 AF XY: 0.000867 AC XY: 297AN XY: 342370
GnomAD4 exome
AF:
AC:
1157
AN:
1049460
Hom.:
Cov.:
30
AF XY:
AC XY:
297
AN XY:
342370
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00994 AC: 1126AN: 113284Hom.: 18 Cov.: 24 AF XY: 0.00917 AC XY: 325AN XY: 35460
GnomAD4 genome
AF:
AC:
1126
AN:
113284
Hom.:
Cov.:
24
AF XY:
AC XY:
325
AN XY:
35460
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 28, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at